An exploratory MRI [magnetic resonance imaging] study in type 2 diabetic subjects: a randomized, double-blinded, placebo-controlled trial to evaluate the measurement of fluid volumes by MRI in the lower extremities of subjects receiving pioglitazone.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Insulin; Metformin; Pioglitazone; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 16 Oct 2008 Biomarkers information updated
- 26 Nov 2006 New trial record.